Skip to content

Effect of Kinesio Taping Combined With Schroth Therapy in Young Adults With Idiopathic Scoliosis

Comparison of Schroth Therapy and Kinesiotaping in Lower Back and Back Pain in Young Adults With Idiopathic Scoliosis: A Double-Blind Placebo-Controlled Randomized Study

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07428083
Enrollment
51
Registered
2026-02-23
Start date
2026-02-01
Completion date
2026-11-01
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kinesio Taping, Scoliosis Idiopathic

Keywords

Scoliosis idiopathic, Kinesio taping, Schroth therapy

Brief summary

In this study, the effects of Kinesio Taping methods applied in combination with Schroth therapy on pain and functional capacity in young adults diagnosed with idiopathic scoliosis will be evaluated. This study is designed as a randomized controlled trial. Participants will be randomly assigned to one of three groups: Group 1: Schroth therapy combined with Kinesio Taping Group 2: Schroth therapy alone Group 3: Schroth therapy combined with sham Kinesio Taping Kinesio Taping will be applied for 4 weeks. The tape will remain in place for 5 consecutive days, followed by a 2-day rest period for the skin, and this cycle will be repeated throughout the intervention period. Schroth therapy will be administered 3 times per week for 4 weeks. Assessments will be conducted at baseline (Week 0), during treatment (Week 2), at the end of treatment (Week 4), and at follow-up (Week 8). The primary outcome measures will be pain intensity assessed by the Numeric Rating Scale (NRS) and functional disability assessed by the Oswestry Disability Index (ODI). Secondary outcome measures will include the Scoliosis Research Society-22 (SRS-22) questionnaire and the Patient Global Impression of Change (PGIC) scale.

Detailed description

The aim of this study is to evaluate the effects of Schroth therapy and the addition of Kinesio Taping on pain, functional capacity, and quality of life in young adults with idiopathic scoliosis who were diagnosed during adolescence and currently experience back pain. Adolescent idiopathic scoliosis (AIS) is a spinal deformity of unknown origin that develops during adolescence, with a worldwide prevalence of 1-3%. The current clinical gold standard for diagnosing scoliosis is the measurement of the Cobb angle on standing posteroanterior radiographs. The Cobb angle determines the severity classification of AIS; a Cobb angle of ≥40° indicates a severe deformity that may require surgical intervention, whereas lower angles are typically managed with non-surgical treatment approaches. Individuals aged 18-30 years are often described as having "young adult idiopathic scoliosis" (YAIS). Even if they received successful conservative treatment during adolescence, these individuals may present in adulthood with pain, progression of deformity, and cosmetic concerns. The development of symptoms in this age group increases the need for treatment, and evaluating the effectiveness of interventions applied during this period is clinically meaningful. The original Schroth exercises were developed in the early 20th century by Katharina Schroth. This exercise-based approach focuses on corrective breathing techniques and postural adjustments to address three-dimensional spinal deformities. Kinesio Taping (KT) is a conservative treatment method that has gained popularity in recent years for managing musculoskeletal conditions and controlling pain. This technique was first described by Kenzo Kase. Since an evidence-based treatment algorithm for managing back pain in patients with idiopathic scoliosis has not yet been clearly established, clinicians often select treatment methods based on preference. Common approaches include home exercise programs, physical therapy, pharmacological treatment (such as acetaminophen, non-steroidal anti-inflammatory drugs, muscle relaxants, or opioid analgesics), back school programs, and spinal manipulation. Both Schroth therapy and Kinesio Taping are non-invasive and conservative treatment methods commonly used in patients with idiopathic scoliosis. Although international studies have evaluated the effectiveness of Schroth therapy and Kinesio Taping separately, and some have explored combined applications, randomized controlled trials including a Schroth therapy group, a combined Schroth + Kinesio Taping group, and a sham taping control group in adult individuals are limited or absent in the national literature. The distinguishing aspect of this study is the controlled and comparative evaluation of the combination of Schroth therapy and Kinesio Taping, rather than assessing each method in isolation. Additionally, the inclusion of a sham taping group allows consideration of potential placebo effects. The findings of this study are expected to contribute to the evidence-based use of non-invasive treatment approaches in the management of idiopathic scoliosis

Interventions

OTHERSchroth Terapisi

Schroth therapy is a scoliosis-specific exercise program designed to address three-dimensional spinal deformities. The intervention includes individualized corrective exercises, rotational angular breathing techniques, postural alignment training, trunk muscle stabilization, and muscular symmetry exercises. Sessions will be supervised by a certified physiotherapist three times per week for 4 weeks.

OTHERKinesio Taping

Kinesio Taping will be applied using elastic therapeutic tape with corrective tension techniques targeting spinal alignment and paraspinal muscle facilitation. The tape will remain in place for 5 consecutive days followed by a 2-day rest period. This cycle will be repeated throughout the 4-week intervention period.

Sham Kinesio Taping will be applied using elastic therapeutic tape without therapeutic tension and without corrective technique. The tape will be placed in a non-corrective manner that does not aim to influence spinal alignment or muscle facilitation. The application schedule will be identical to the experimental taping group (5 days on, 2 days off for 4 weeks) to maintain participant blinding.

Sponsors

Fatih Sultan Mehmet Training and Research Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Masking description

Both the researcher/evaluator and the participant are blind.

Intervention model description

Double-blind, placebo-controlled, randomized prospective parallel group study.

Eligibility

Sex/Gender
ALL
Age
18 Years to 30 Years
Healthy volunteers
No

Inclusion criteria

* Individuals aged between 18 and 30 years. * Radiologically confirmed diagnosis of idiopathic scoliosis. * Cobb angle between 10° and 30° and considered candidates for conservative treatment. * Risser stage 5. * History of low back or back pain within the last 3 months (defined as NRS ≥ 4). * No acute orthopedic or neurological condition that would prevent participation in physical exercise interventions. * Willingness to participate voluntarily and provide written informed consent. * Ability to attend treatment sessions regularly throughout the study period.

Exclusion criteria

* Diagnosis of non-structural (functional) scoliosis, congenital scoliosis, or neuromuscular scoliosis. * History of previous spinal surgery. * Participation in scoliosis-specific exercise therapy within the last 6 months. * Presence of open wounds, dermatological conditions, or allergy to taping materials. * History of psychiatric disorders or neurological diseases.

Design outcomes

Primary

MeasureTime frameDescription
Change in Pain Intensity (NRS)Baseline (Week 0), Week 2, Week 4, and Week 8Pain intensity will be assessed using the Numeric Rating Scale (NRS), scale ranging from 0 (no pain) to 10 (worst imaginable pain). Changes in pain intensity will be evaluated across all assessment time points during the study
Change in Functional Disability (ODI)Baseline (Week 0), Week 4, and Week 8Functional disability will be assessed using the Oswestry Disability Index (ODI), a validated questionnaire designed to measure disability related to low back pain. The ODI consists of 10 items evaluating daily living activities, with higher scores indicating greater disability. Changes in functional disability will be evaluated across the specified assessment time points.

Secondary

MeasureTime frameDescription
Change in Scoliosis-Specific Quality of Life (SRS-22)Baseline (Week 0), Week 4, and Week 8Quality of life will be assessed using the Scoliosis Research Society-22 (SRS-22) questionnaire, a scoliosis-specific, validated instrument that evaluates function/activity, pain, self-image, mental health, and satisfaction with management. Higher scores indicate better health-related quality of life. Changes in SRS-22 scores will be evaluated across the specified assessment time points.
Patient Global Impression of Change (PGIC)Week 2, Week 4, and Week 8Global perceived improvement will be assessed using the Patient Global Impression of Change (PGIC) scale, a patient-reported outcome measure evaluating overall change in condition following treatment. The PGIC is a 7-point scale ranging from "very much worse" to "very much improved."

Countries

Turkey (Türkiye)

Contacts

CONTACTŞevval Çakmakcı Alkayış, MD
sevvalcakmakci@outlook.com+905556455465
CONTACTOzge G İlleez, MD
ozgeilleez@hotmail.com+905326255684

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 3, 2026